CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
We need your help
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
A 42-year-old HIV patient with leukemia continues to show no signs of HIV in his blood, two years after a stem cell transplant from a donor with a gene mutation that confers natural resistance to the virus that causes AIDS.
The stunning findings were published Wednesday in The New England Journal of Medicine, according to CNN, but doctors caution that the stem cell treatment is too dangerous to be of routine use to most people infected with HIV.
In the study, reported CNN, "the team deliberately chose a compatible donor who has a naturally occurring gene mutation that confers resistance to HIV. The mutation cripples a receptor known as CCR5, which is normally found on the surface of T cells, the type of immune system cells attacked by HIV.
"The mutation is known as CCR5 delta32 and is found in 1 percent to 3 percent of white populations of European descent.
"HIV uses the CCR5 as a co-receptor (in addition to CD4 receptors) to latch on to and ultimately destroy immune system cells. Since the virus can't gain a foothold on cells that lack CCR5, people who have the mutation have natural protection. (There are other, less common HIV strains that use different co-receptors.)
"People who inherit one copy of CCR5 delta32 take longer to get sick or develop AIDS if infected with HIV. People with two copies (one from each parent) may not become infected at all. The stem cell donor had two copies."
Doctors say that while the risky stem cell transplant option should not be routinely exercised, the findings point the way toward development of potentially safer CCR5-disabling gene therapies or treatments that can be injected into the body.
From our Sponsors
Most Popular
Bizarre Epstein files reference to Trump, Putin, and oral sex with ‘Bubba’ draws scrutiny in Congress
November 14 2025 4:08 PM
True
Jeffrey Epstein’s brother says the ‘Bubba’ mentioned in Trump oral sex email is not Bill Clinton
November 16 2025 9:15 AM
True
Watch Now: Pride Today
Latest Stories
HIV-positive men stage 'Kiss-In' protest at U.S.-Mexico border (in photos)
December 01 2025 12:56 PM
Maryland community outraged after ‘bigoted’ early morning rainbow crosswalk removal
December 01 2025 11:07 AM
19 LGBTQ+ movies & TV shows coming in December 2025 & where to watch them
December 01 2025 9:00 AM
Gay NYC councilman running for Congress says America is at a crossroads
December 01 2025 6:52 AM
What the AIDS crisis stole from Black gay men
December 01 2025 6:00 AM
Japan's ban on marriage equality is constitutional, according to a Tokyo court
November 28 2025 4:59 PM
How a queer fashion show took on New York Fashion Week
November 28 2025 4:58 PM
8 LGBTQ+ films coming in 2026 that we can't wait to see
November 28 2025 12:00 PM




































































Charlie Kirk DID say stoning gay people was the 'perfect law' — and these other heinous quotes